80 Results

People

  1. Levine
    Levine
  2. Tallman
    Tallman
  3. Abdel-Wahab
    Abdel-Wahab
  4. Kleppe
    Kleppe
  5. Papaemmanuil
    Papaemmanuil
  6. Patel
    Patel
  7. Famulare
    Famulare
  8. Getta
    Getta
  9. Bowman
    Bowman
  10. Devlin
    Devlin

Groups

  1. Adult Leukemia (80)
  2. Center for Hematologic Malignancies (80)
  3. Department of Medicine (80)
  4. Executive Committee, Center for Hematologic Malignancies (80)
  5. GSK Faculty (80)
  6. Hematologic Malignancies, Division of (80)
  7. Human Oncology and Pathogenesis Program (80)
  8. Sloan Kettering Institute Postdocs (80)
  9. Tow Center for Developmental Oncology (TCDO) (32)
  10. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (30)
  1. "Meeting abstract"
  2. "Sloan Kettering Institute Postdocs"
  3. "GSK Faculty"
  4. "Ross Levine"
Formats
  1. Meeting Abstract (80)
Groups
  1. Adult Leukemia (80)
  2. Center for Hematologic Malignancies (80)
  3. Department of Medicine (80)
  4. Executive Committee, Center for Hematologic Malignancies (80)
  5. GSK Faculty (80)
  6. Hematologic Malignancies, Division of (80)

More Groups

People
  1. Ross Levine (80)
  2. Martin Tallman (18)
  3. Omar Abdel-Wahab (15)
  4. Maria Kleppe (14)
  5. Elli Papaemmanuil (13)
  6. Minal Patel (13)

More People

Years
  1. 2023 (4)
  2. 2022 (2)
  3. 2021 (5)
  4. 2020 (6)
  5. 2019 (9)
  6. 2018 (13)

More Years

Publications
  1. Blood (60)
  2. Cancer Research (10)
  3. Clinical Cancer Research (2)
  4. Haematologica (2)
  5. Cancer Prevention Research (1)
  6. Experimental Hematology (1)

More Publications

Publishers
  1. American Society of Hematology (60)
  2. American Association for Cancer Research (13)
  3. Elsevier Science, Inc. (2)
  4. Ferrata Storti Foundation (2)
  5. American Society of Clinical Oncology (1)
  6. E M H Swiss Medical Publishers Ltd (1)

More Publishers

Results (80)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pro-inflammatory gene signature characterizes a better risk aged AML patient group in ECOG-ACRIN Cancer Research Group's clinical trial E3999
    Meeting Abstract

    Neelamraju, Y.; Rapaport, F.; Gandara, J. A.; Dunham, N.; Fan, H.; Lee, T.; Prajapati, S.; Sheridan, C.; Wang, L.; Cripe, L. D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
    Meeting Abstract

    Sirenko, M.; Lee, S.; Sun, Z.; Chaligne, R.; Asimomitis, G.; Brierley, C. K.; Bernard, E.; Cai, S. F.; Myers, R. M.; Nadorp, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Targeting JAK1 signaling for molecular prevention in clonal hematopoiesis
    Meeting Abstract

    Vela, P. S.; Wang, R.; Tran, D.; Benitez, A. M.; Krishnan, A.; O'Connor, K.; Liu, W.; Kleppe, M.; Bowman, R.; Cai, S.; more...
    Experimental Hematology (2023)

    Fulltext@MSK | Save
  • Targeting JAK1 signaling for molecular prevention in clonal hematopoiesis
    Meeting Abstract

    Sánchez Vela, P.; Benitez, A. M.; Krishnan, A.; Kleppe, M.; Cai, S. F.; Levine, R. L.
    Cancer Prevention Research (2023)

    Fulltext@MSK | Save
  • Single cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia
    Meeting Abstract

    Robinson, T.; Bowman, R. L.; Persaud, S.; Liu, Y.; Gao, Q.; Zhang, J. P.; Sun, X.; Sciambi, A.; Llanso, A.; Famulare, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • JAK2(V617F) reversible activation shows an essential requirement for JAK2(V617F) in myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Dunbar, A.; Bowman, R. L.; Park, Y.; Izzo, F.; Myers, R. M.; Karzai, A.; Kim, W. J.; Maestre, I. F.; Waarts, M. R.; Nazir, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Clonotype-immunophenotype relationships in TET2 and IDH-mutant myeloid transformation
    Meeting Abstract

    Miles, L. A.; Bowman, R. L.; Delgaudio, N.; Robinson, T.; Carroll, M. P.; Meyer, S. E.; Levine, R. L.
    Blood (2021)

    Fulltext@MSK | Save
  • The BMP/SMAD pathway is a key mediator of leukemic transformation of TP53-mutant post-MPN AML
    Meeting Abstract

    Li, B.; An, W.; Wang, H.; Krishnan, A.; Mowla, S.; Baslan, T.; Koche, R.; Xiao, W.; Lowe, S.; Levine, R. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • DNMT3A mutations in the hematopoietic system promote colitis-associated colon cancer: A model of clonal hematopoiesis in solid tumors
    Meeting Abstract

    Feng, Y.; Newsome, R.; Robinson, T.; Bowman, R. L.; Zuniga, A.; Hall, K.; Bernsten, C.; Shabashvili, D.; Krajcik, K.; Gunaratne, C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Multi-recombinase mouse models of FLT3-driven leukemia identifies distinct trajectories of mutational cooperativity and leukemic transformation
    Meeting Abstract

    Bowman, R. L.; Mishra, T.; Eisman, S. E.; Cai, L.; Xiao, W.; Waarts, M. R.; Sanchez Vela, P.; Fernández-Maestre, I.; Csete, I. S.; Potts, C. R.; more...
    Blood (2021)

    Fulltext@MSK | Save